LIVRAISON GRATUITE À PARTIR DE €90.00
JUSQU'À 16.00 COMMANDÉS, EXPÉDIÉ LE JOUR MÊME
KLARNA, PAYPAL, CARTE DE CRÉDIT

Les références à des Affirmations sur le présent Site web ont été prises:

  1. Pepper, Ian L. “The soil health human health nexus.” Critical Reviews in Environmental Science and Technology43, no. 24 (2013): 2617-2652.
  2. de Grebmer, Klaus, Amy Saltzman, Ekin Birol, Doris Wiesman, Nilam Actuellement, Sandra Yin, Yisehac Yohannes, Purnima Menon, Jennifer Thompson, and Andrea Dimanche. Synopsis: 2014 Index Mondial de la Faim: The challenge of hidden faim. Vol. 83. International Food Policy Res Inst, 2014.
  3. Senesi et E. Loffredo, “The chemistry of soil organic matter,” dans le Sol Physical Chemistry, pp. 239-370, CRC Press, Boca Raton, FL, états-UNIS, 2e édition, 1999. View at Google Scholar
  4. Jill Thomas N D, “Healthy Bon Guide: Natural Solutions for your Digestif Disorders,” Penguin Books Ltd, Londres, Angleterre, 2007
  5. DePoalis, F., Kukkonen, J. (1997). Binding of organic pollutants to humique and fulvic acids: influence of pH and the structure of humique matériel. Chemosphere, 34(8), 1693-1704.
  6. V. Vucskits, I. Hullár, A. Bersényi, E. Andrásofszky, M. Kulcsár, and J. Szabó, “Effect of fulvic and humique acids on performance de, réponse immunitaire and thyroid function en conseil, Journal of Animal Physiology and Animal Nutrition, vol. 94, no. 6, pp. 721-728, 2010. View at Publisher • View at Google Scholar • View at Scopus
  7. Kunavue and T. F. Lien, “Effects of fulvic acid and probiotic on growth performance, nutrient digestibility, blood parameters and immunity of pigs,” Journal of Animal Science Avances, vol. 2, no. 8, pp. 711-721, 2012. View at Google Scholar
  8. C. Rodríguez, E. C. Urrutia, B. H. Gertrudis, J. P. Chaverri, and G. B. Mejía, “Antioxidant activity of fulvic acid: a living matter-derived bioactive compound,” Journal of Food, Agriculture & Environnement, vol. 9, pp. 123-127, 2011. View at Google Scholar
  9. Surapaneni, Dinesh Kumar, Sree Rama Shiva Shanker Adapa, Kumari Preeti, Gangineni Ravi Teja, Muruganandam Veeraragavan, and Sairam Krishnamurthy. “Shilajit attenuates comportementale symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitaire–adrenal axis and mitochondrial bioenergetics en conseil.” Journal of ethnopharmacology143, no. 1 (2012): 91-99.
  10. Stohs, Sidney J. “Safety and efficacy of shilajit (momie, moomiyo).” Phytotherapy Research28, no. 4 (2014): 475-479.
  11. L. Round and S. K. Mazmanian, “The gut microbiota formes intestinales immune responses during health and disease”, Nature Reviews Immunology, vol. 9, no. 5, pp. 313-323, 2009. View at Publisher • View at Google Scholar • View at Scopus
  12. N. V. Priya, K. Mahavishnan, D. S. Gurumurthy, H. Bindumadhava, A. P. Upadhyay, and N. K. Sharma, “Fulvic acid (FA) for enhanced nutrient uptake and growth: insights from biochemical and genomic studies, Journal of Crop Improvement, vol. 28, no. 6, pp. 740-757, 2014. View at Publisher • View at Google Scholar • View at Scopus
  13. A. Mirza, N. Ahmed, S. P. Agarwal, D. Mahmood, M. Khalid Anwer, and Z. Iqbal, “Comparative evaluation of humique substances par voie orale drug delivery,” Results pharmaceutiques Sciences, vol. 1, no. 1, pp. 16-26, 2011. View at Publisher • View at Google Scholar • View at Scopus

OcuSolve Eye Wash:

  1. Chen J, Xie H, Wang Z, Yang B, Liu Z, Chen L, Gong X, Lin Y. Marais’s ulcer en Chine: a study of clinical characteristics and treatment. Br. J. Ophthalmol. 2000;84:1244-1249. [PMC free article][PubMed] [Google Scholar]
  2. Srinivasan M, Zegans ME, Zelefsky JR, Kundu A, Lietman T, Whitcher JP, Cunningham ET al., Jr Clinical characteristics of Marais’s ulcer dans le sud de l'inde. Br. J. Ophthalmol. 2007;91:570-575. [PMC free article][PubMed] [Google Scholar]
  3. Zegans ME, Srinivasan M. Marais’s Ulcère. Clin. Ophthalmol. 1996;36:81-88. [Google Scholar]
  4. Markomichelakis NN, Canakis C, Zafirakis P, L'T, Mallias I, Theodossiadis G. Cytomégalovirus as a cause of uvéite antérieure with sectoral iris atrophy. Ophthalmology. 2002;109:879-882. [PubMed] [Google Scholar]
  5. Yoser SL, Forster DJ, Rao NA. Systemic Viral Infections and their rétinien and choroidal manifestations. Orar. Ophthalmol. 1993;37:313-352. [PubMed] [Google Scholar]
  6. Craig EL, Suie T. Histoplasma Capsulatum dans Human Ocular Tissue. Arch.
  7. Gonzales CA, Scott IU, Chaudhry NA, Luu KM, Miller D, Murray TG, Davis JL. Endogenous endophtalmie caused by Histoplasma capsulatum var. capsulatum: a case report and literature review. Ophthalmology. 2000;107:725-729. [PubMed] [Google Scholar]
  8. Hawkins BS, Alexandre J, Schachat AP. Dans: Ocular histoplasmosis.Ryan SJ, éditeur. Saint-Louis: Retina Mosby; 1994. pp. 1661-1675. [Google Scholar]
  9. Scholz R, Green WR, Kutys R, Sutherland J, Richards RD. Histoplasma capsulatum dans the eye. Ophthalmology. 1984;91:1100-1104. [PubMed] [Google Scholar]
  10. Bakunowicz-Lazarczyk A, Maciorkowska E, Antosiuk R, Kaczmarski M. Helicobacter pylori as supposed factor of uvéite in children: a case report. Klin. Oczna. 1999;101:463-465. [PubMed] [Google Scholar]
  11. Otasevic L, Walduck A, Meyer TF, Aebischer T, Hartmann, C, Orlic N, le Baladeur, Entre Helicobacter pylori infection dans une uvéite antérieure. Infection. 2005;33:82-85. [PubMed] [Google Scholar]
  12. Otasevic L, Zlatanovic G, Stanojevic-Paovic A, Miljkovic-Selimovic B, Dinic M, Djordjevic-Jocic J Stankovic, A. Helicobacter pylori: à underestimated factor in acute uvéite antérieure and spondyloarthropathies? Ophthalmologica. 2007;221:6-13. [PubMed] [Google Scholar]
  13. Cancino-Diaz JC, Vargas, Rodríguez L, Grinberg-Zylberbaum N, Reyes-López MA, Dominguez-Lopez ML, Pablo-Velazquez A, Cancino-Diaz ME. High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica dans sera of patients with uvéite. Br. J. Ophthalmol. 2004;88:247-250. [PMC free article][PubMed] [Google Scholar]
  14. Careless DJ, Chiu B, Rabinovitch T, Wade J, Inman RD. Immunogenetic and microbial factors in acute uvéite antérieure. J. Rheumatol. 1997;24:102-108. [PubMed] [Google Scholar]
  15. Huhtinen M, Laasila K, Granfors K, Puolakkainen M, Seppälä I, Laasonen L, Repo H, le Karma A, Leirisalo des opérations de pension de M. Infectious background of patients with a history of acute uvéite antérieure. Ann. Rheum. Dis. 2002;61:1012-1016. [PMC free article][PubMed] [Google Scholar]
  16. Larkin F. Yersinia infection in acute uvéite antérieure. Arch. Ophthalmol. 1990;108:1515-1516. [PubMed] [Google Scholar]
  17. Osusky R, Caïn HL. Uvéite after Yersinia enterocolitica infection. Klin. Monbl. Augenheilkd. 1991;198:451-452. [PubMed] [Google Scholar]
  18. Arora R, S, Chauhan D, Daraius S, Narula R, Sachdev R. Bilatérale endogenous panophthalmitis caused by Salmonella typhi: first case report. Orbit. 2008;27:115-117. [PubMed] [Google Scholar]
  19. Yodprom R, Pathanapitoon K, Kunavisarut P, Ausayakhun S, Wattananikorn S, Rothova A. Endogenous endophtalmie due to Salmonella choleraesuis dans le VIH-positifs patient. Ocul. Immunol. Inflamm. 2007;15:135-138. [PubMed] [Google Scholar]
  20. Sprenkels SH, Van Kregten E, Feltkamp TE. IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis, and acute uvéite antérieure. Clin. Rheumatol. 1996;S1:48-51. [PubMed] [Google Scholar]
  21. Altiparmak UE, Ozer PA, Ozkuyumcu C, Us AD, Aslan, BS, Duman S. endophtalmie post-Opératoire caused by Bacillus cereus and Chlamydia trachomatis. J. Cataract Rides. Surg. 2007;33:1284-1287. [PubMed] [Google Scholar]
  22. Garg SP, Bajaj MS, Jaffery NF, Mahajan VM. Chlamydial serology dans uvéite. Rév. Int. Trach. Pathol. Ocul. Trop. Subtrop. 1989;66:7-20. [PubMed] [Google Scholar]
  23. Haller-Schober EM, El-Shabrawi Y. Chlamydial conjonctivite (in adults), une uvéite, and reactive arthrite, including SARA. Sexually acquired reactive arthrite. Best Pract. Rés. Clin. Obstet. Gynaecol. 2002;16:815-828. [PubMed] [Google Scholar]
  24. Huhtinen M, Puolakkainen M, Laasila K, Sarvas M, Karma A, Leirisalo des opérations de pension de M. Chlamydial antibodies in patients with previous acute uvéite antérieure. Invest. Ophthalmol.Vis. Sci. 2001;42:1816-1819. [PubMed] [Google Scholar]
  25. Krichevskaia GI, Vakhova IL, Maĭchuk F, Davydova GA. Implication of Chlamydia trachomatis dans the etiopathogenesis of uvéite antérieure. Vestn Oftalmol. 2008;124:48-51. [PubMed] [Google Scholar]
  26. Numazaki K, Chiba S, Aoki K, Suzuki K, Ohno S. Detection of sérum antibodies to Chlamydia pneumoniae in patients with endogenous uvéite and acute conjonctivite. Clin. Infect. Dis. 1997;25:928-929. [PubMed] [Google Scholar]
  27. Khairallah M, Chee SP, Rathinam SR, Attia S, Nadella V. Novel infectious agents causant une uvéite. Int. Ophthalmol. 2010;32:465-483. [PubMed] [Google Scholar]
  28. Requerant AJ, Herbort CP. Acute acquired toxoplasmique retinochoroiditis in a patient with uvéite antérieure, amplified by immunosuppressives therapy. Int. Ophthalmol. 2009;29:191-193. [PubMed] [Google Scholar]
  29. Melamed J, Eckert GU, Spadoni VS, Lago CE, Uberti F. Ocular manifestations of congenital
  30. Curi A, Matos, K, Pavesio, C. Acute uvéite antérieure. Clin. Evid. 2005;14:739-743. [PubMed] [Google Scholar]
  31. Read RW. Uvéite: advances in understanding of pathogenesis. Curr. Rheumatol.
  32. Rathinam SR, Cunningham ET al., Jr Infectious causes of uvéite in the developing world. Int. Ophthalmol. Clin. 2000;40:137-152. [PubMed] [Google Scholar]
  33. Valais, S, Macierewicz J, Shrestha BM. Behcet’s Disease: report of a case and review of the literature. J. Népal Med. Assoc. 2006;45:362-365. [PubMed] [Google Scholar]
  34. Alebiosu CO, Raimi TH, Badru AI, Amore OO, Ogunkoya JO, Odusan O. Onglet’s syndromes a case report and review of literature. Afr. Health Sci. 2004;4:136-138. [PMC free article][PubMed] [Google Scholar]
  35. Amor B. Onglet’s syndrome. Diagnosis and clinical features. Rheum. Dis. Clin. North Am. 1998;24:677-695. [PubMed] [Google Scholar]
  36. Cuttica RJ, Coupure EJ, Garay SM, Romanelli MC, Maldonado CJA. Juvénile onset Onglet’s syndrome. A retrospective study of 26 patients. Clin. Exp. Rheumatol. 1992;10:285-288. [PubMed] [Google Scholar]
  37. François J. Cortisone et de la tension oculaire. Ann D’Oculiste 1954; 187: 805.
  38. Cantrill HL, Palmberg, Zinc HA, Waltman SR, Podos SM, Becker B. Comparison of in vitro potency of corticostéroïde with ability to raise intraocular pressure. Am J Ophthalmol 1975; 79: 1012-1017.
  39. François J. Corticostéroïde glaucome. Ann Ophthalmol 1977; 9: 1075-1080.
  40. James-IL. The etiology of steroid de la cataracte. J Ocul Pharmacol Ther 2007;23:403-20.
  41. Moran CORE | Cataracts. http://morancore.utah.edu/medical-student-education-outline/cataracts/ (accessed 28 Jul 2018)
  42. Srinivasan M, Mascarenhas J, Rajaraman R, et al. The Steroids for Corneal Ulcers Trial. Arch Ophthalmol 2012;130.
  43. Medina-Tamayo J, Sanchez-Miranda E, Balleza-Tapia H, et al. Super-oxidized solution inhibits IgE antigène-induced dégranulation and cytokine release dans mast cells. Int Immunopharmacol. 2007;7(8):1013-1024.
  44. Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous acid: à l'idéal wound care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26(12): 342-350.
  45. Pelgrift R, Friedman AJ. Topique hypochlorous acid (HOCl) as a potential treatment of prurit. Curr Derm, Rép. De 2013;2:181-190.
  46. Bongiovanni CM. Effects of hypochlorous acid solutions on venous leg ulcers (VLU): experience With 1249 VLUs dans 897 patients. J Am Coll Clin Wound Spec. 2014;6(3):32-37
  47. Gottrup F. Oxygen in wound healing and infection. World J Surg 2004; 28(3):312–315. https://doi.org/10.1007/s00268-003-7398-5
  48. en CK. Wound healing essentials: let there be oxygen. Wound Repair Regen 2009; 17(1):1–18. https://doi.org/10.1111/j.1524-475X.2008.00436.x
Select your currency
CHF Swiss franc
EUR Euro